PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Clinical trial NCT06683612 · COMPLETED

Trial details

NCT number: NCT06683612
Sponsor: Contineum Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis Multiple Sclerosis Multiple Sclerosis, MS Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Multiple Sclerosis, Secondary Progressive Healthy Healthy Volunteers

Start date: 2024-12-09
Primary completion: 2025-06-04
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.